| Pieris Pharmaceuticals, Inc. PIRS | $1.61B | 664.97 | 8.78M | -10.2% | -$182.59M | 84.78 | |
TScan Therapeutics, Inc. TCRX | $41.48M | 9.88 | 5.22M | 0% | +$0 | 2.19 | |
| Passage Bio, Inc. PASG | $6.54M | 7.86 | 4.85M | +1,178.06% | +$6.03M | 0.35 | |
| Stoke Therapeutics, Inc. STOK | $49.91M | 7.09 | 3.7M | +25.02% | +$9.99M | 2.63 | |
GH Research PLC GHRS | $35.29M | 6.36 | 3.31M | +80.06% | +$15.69M | 1.86 | |
| C4 Therapeutics, Inc. CCCC | $29.7M | 5.28 | 3.63M | +15.96% | +$4.09M | 1.57 | |
| Cabaletta Bio, Inc. CABA | $35.54M | 4.32 | 2.08M | -1.3% | -$467,921.67 | 1.87 | |
| Merus N.V. MRUS | $67.95M | 2.57 | 1.51M | +32.93% | +$16.83M | 3.58 | |
Silence Therapeutics plc SLN | $11.38M | 1.13 | 526,642 | +123.36% | +$6.28M | 0.6 | |
| Nektar Therapeutics NKTR | $1.93M | 1.13 | 2.07M | +7.24% | +$130,455.41 | 0.1 | |
Autolus Therapeutics plc AUTL | $8.87M | 0.52 | 1.39M | -25.2% | -$2.99M | 0.47 | |
| Centessa Pharmaceuticals plc CNTA | $196,620.00 | 0.02 | 17,400 | New | +$196,620.00 | 0.01 |